Article
A Pool of Eight Virally Vectored African Swine Fever Antigens Protect Pigs against Fatal Disease
18 May 2020
Abstract excerpt
Classical approaches to African swine fever virus (ASFV) vaccine development have not been successful; inactivated virus does not provide protection and use of live attenuated viruses generated by passage in tissue culture had a poor safety profile. Current African swine fever (ASF) vaccine research focuses on the development of modified live viruses by targeted gene deletion or subunit vaccines. The latter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
